113 related articles for article (PubMed ID: 8074491)
1. The antimetastatic effect of IV-inoculated BCG on adenocarcinomas in the prostate-seminal vesicle complex of L-W rats.
Pollard M; Luckert PH
Anticancer Res; 1994; 14(3A):901-3. PubMed ID: 8074491
[TBL] [Abstract][Full Text] [Related]
2. The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells.
Pollard M; Luckert PH
Anticancer Res; 1993; 13(3):705-8. PubMed ID: 8317900
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.
Pollard M; Luckert PH
Anticancer Res; 1994; 14(6B):2691-4. PubMed ID: 7872703
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
Hodde JP; Suckow MA; Wolter WR; Hiles MC
J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
[TBL] [Abstract][Full Text] [Related]
5. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
6. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats.
Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC
Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
8. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.
Pollard M; Luckert PH
J Natl Cancer Inst; 1986 Aug; 77(2):583-7. PubMed ID: 3461217
[TBL] [Abstract][Full Text] [Related]
9. Use of an extracellular matrix material as a vaccine carrier and adjuvant.
Suckow MA; Hall P; Wolter W; Sailes V; Hiles MC
Anticancer Res; 2008; 28(5A):2529-34. PubMed ID: 19035274
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
11. Phenobarbital promotes multistage pulmonary carcinogenesis in MNU-inoculated L-W rats.
Pollard M; Luckert PH
In Vivo; 1997; 11(1):55-60. PubMed ID: 9067774
[TBL] [Abstract][Full Text] [Related]
12. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
13. Transplantable metastasizing prostate adenocarcinomas in rats.
Pollard M; Luckert PH
J Natl Cancer Inst; 1975 Mar; 54(3):643-9. PubMed ID: 1123852
[TBL] [Abstract][Full Text] [Related]
14. Phenobarbital promotes the development of adenocarcinomas in the accessory sex glands of MNU-inoculated L-W rats.
Pollard M; Luckert PH; Scheu J
Carcinogenesis; 1995 Oct; 16(10):2419-21. PubMed ID: 7586145
[TBL] [Abstract][Full Text] [Related]
15. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.
Slayter MV; Anzano MA; Kadomatsu K; Smith JM; Sporn MB
Cancer Res; 1994 Mar; 54(6):1440-5. PubMed ID: 8137245
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of a polyherbal preparation, Brahma rasayana against tumor growth and lung metastasis in rat prostate model system.
Gaddipati JP; Rajeshkumar NV; Thangapazham RL; Sharma A; Warren J; Mog SR; Singh AK; Maheshwari RK
J Exp Ther Oncol; 2004 Oct; 4(3):203-12. PubMed ID: 15724840
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant immunotherapy (BCG) in stage D prostate cancer.
Guinan PD; John T; Baumgartner G; Sundar B; Ablin RJ
Am J Clin Oncol; 1982 Feb; 5(1):65-8. PubMed ID: 7081139
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
